For example, in colon cancer, miR-181b was able to target CYLD to inhibit the NF-κB signaling pathway 60, while, in cervical cancer, miR-501 can target CYLD to regulate cell proliferation, migration and invasion 61. Here, CYLD is linked to malignant colon neoplasm.